Viewing Study NCT06179056



Ignite Creation Date: 2024-05-06 @ 7:54 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06179056
Status: COMPLETED
Last Update Posted: 2024-04-23
First Post: 2023-11-26

Brief Title: Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
Sponsor: Zagazig University
Organization: Zagazig University

Study Overview

Official Title: Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate and compare the anti-biofilm activity of Salicylic acid Isotretinoin and N-acetylcysteine against C acne
To assess the possible role of Salicylic acid Isotretinoin and N-acetylcysteine in improving the susceptibility of C acne for Azithromycin and Doxycycline
Detailed Description: The study was carried out on 24 patients with acne vulgaris They were recruited from the outpatient clinic of the Dermatology and Venereology and Andrology Department Zagazig University Hospitals Egypt

The degree of severity of lesions was determined by the global acne grading system GAGS

Microbiological samples were collected from all patients for

1 Isolation of C acnes
2 Antibiotic susceptibility testing for C acnes isolates aganist the most commonly used antibiotics in treatment of acneAzithromycin and Doxycycline in the presence and absence of Salicylic acid Isotretinoin and N-acetylcysteine
3 Testing biofilm forming ability of C acnes isolates in the presence and absence of Salicylic acid Isotretinoin and N-acetylcysteine

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None